Full Year 2024 Highlights
Total Revenue: Nutex Health reported total revenue of $479.9 million for the fiscal year 2024, marking a remarkable 93.8% increase compared to $247.6 million in 2023.
Net Income: The company's net income attributable to Nutex Health Inc. surged to $52.1 million in 2024, skyrocketing from a net loss of $45.8 million in the previous year.
Income Per Share: Diluted income per share rose to $9.69 from a loss per share of $10.39 in 2023.
EBITDA: For 2024, Nutex achieved an EBITDA of $98.8 million, a significant recovery from $(22.5) million in 2023.
Adjusted EBITDA: The adjusted EBITDA reached an astounding $124.1 million in 2024, reflecting a phenomenal increase of 1046.1% compared to $10.8 million in 2023.
Operating Cash: The company's net cash from operating activities reached $23.2 million in 2024.
Company Overview
Nutex Health Inc. (NASDAQ: NUTX), founded in 2011, operates a diverse healthcare management system that includes innovative healthcare models like micro-hospitals and specialty hospitals. The company manages 24 facilities across 11 states, focusing on enhancing the quality of care through its two divisions: Hospital Division and Population Health Management Division.
Financial Restatement Background
The Audit Committee of the Board of Directors conducted a review and determined that previously issued financial statements needed restatement. This decision was based on non-cash adjustments impacting balance sheet accounts.
Adjustments Impacting Financial Statements
The adjustments as of December 31, 2024, resulted in a net increase in liabilities of $13.4 million and a corresponding decrease in equity, amounting to $13.4 million. Notably, net income fell slightly by approximately $0.5 million.
Quarterly Financial Performance
During the three months ending December 31, 2024, total revenue surged to $257.6 million, up from $69.7 million in the same quarter of the previous year, marking an impressive growth rate of 269.8%. The company recorded an operating income of $114.3 million, reversing from a loss of $26.1 million in 2023.
Future Outlook
Looking forward into 2025, Nutex Health intends to capitalize on its strategic growth initiatives and expects to see continued improvement in its financial metrics. The management remains confident about the long-term prospects of the company and plans to execute stock repurchase programs to enhance shareholder value.
Frequently Asked Questions
1. What were Nutex Health's total revenues for 2024?
Total revenues for Nutex Health in 2024 were $479.9 million.
2. How much net income did the company report?
The company reported a net income of $52.1 million for the year 2024.
3. What is the significance of the EBITDA figures reported?
Nutex Health recorded an EBITDA of $98.8 million for 2024, which indicates substantial financial recovery from the previous year's performance.
4. What strategic measures is Nutex Health implementing for future growth?
The company focuses on expanding its micro-hospitals and enhancing care delivery quality, coupled with expected stock repurchase programs.
5. How does this financial turnaround affect investors?
This turnaround demonstrates Nutex Health's strong operational metrics and growth potential, making it a promising investment opportunity.
